Stock Earnings

Question 1

What are Kalvista Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Kalvista Pharmaceuticals Inc has a total asset of $250, Net loss of $0

Question 2

What are the key financial ratios for KALV?

Accepted Answer

Kalvista Pharmaceuticals Inc's Current ratio is 1.61, has a Net margin is 0, sales per share of $0.

Question 3

How is Kalvista Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Kalvista Pharmaceuticals Inc data is not available.

Question 4

Is Kalvista Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, Kalvista Pharmaceuticals Inc has a net loss of $0

Question 5

Does Kalvista Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Kalvista Pharmaceuticals Inc has liability of 155

Question 6

How many outstanding shares for Kalvista Pharmaceuticals Inc?

Accepted Answer

Kalvista Pharmaceuticals Inc has a total outstanding shares of 49.76

Breakdown	TTM	04/30/2025	04/30/2024	04/30/2023	04/30/2022	04/30/2021
Revenue	15	--	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	-100%
Cost of Revenue	1	--	--	--	--	--
Gross Profit	13	--	--	--	--	--
Selling, General & Admin	91	--	54	30	26	16
Research & Development	27	--	86	80	70	41
Operating Expenses	118	--	140	110	96	57
Other Non Operating Income (Expenses)	3	--	8	15	14	9
Pretax Income	-105	--	-126	-92	-82	-46
Income Tax Expense	4	--	0	0	0	0
Net Income	-109	--	-126	-92	-82	-46
Net Income Growth	--	--	37%	12%	78%	59%
Shares Outstanding (Diluted)	53.88	--	36.78	27.89	24.47	19.09
Shares Change (YoY)	--	--	32%	14%	28%	8%
EPS (Diluted)	-2.04	--	-3.44	-3.33	-3.36	-2.42
EPS Growth	--	--	3%	-1%	39%	48%
Free Cash Flow	-202	-153	-89	-76	-79	-30
Free Cash Flow Per Share	-3.74	--	-2.41	-2.72	-3.22	-1.57
Gross Margin	86.66%	--	--	--	--	--
Operating Margin	-700%	--	0%	0%	0%	0%
Profit Margin	-726.66%	--	0%	0%	0%	0%
Free Cash Flow Margin	-1,346.66%	--	0%	0%	0%	0%
EBITDA	-104	--	-140	-110	-96	-57
EBITDA Margin	-693.33%	--	0%	0%	0%	0%
D&A For EBITDA	1	0	0	0	0	0
EBIT	-105	--	-140	-110	-96	-57
EBIT Margin	-700%	--	0%	0%	0%	0%
Effective Tax Rate	-3.8%	--	0%	0%	0%	0%

Kalvista Pharmaceuticals Inc (KALV) Price